Article info

Original research
Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial

Authors

  1. Correspondence to Dr Anne Marit Solheim, Department of Neurology, Sørlandet sykehus HF Kristiansand, Kristiansand, Norway; anne.marit.solheim{at}sshf.no
View Full Text

Citation

Solheim AM, Lorentzen ÅR, Dahlberg AO, et al
Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial

Publication history

  • Received June 1, 2022
  • Accepted July 12, 2022
  • First published July 27, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.